Free Trial

Insider Selling: Keurig Dr Pepper Inc. (NASDAQ:KDP) Director Sells 208,000 Shares of Stock

Keurig Dr Pepper logo with Consumer Staples background

Keurig Dr Pepper Inc. (NASDAQ:KDP - Get Free Report) Director Robert James Gamgort sold 208,000 shares of the company's stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $33.10, for a total value of $6,884,800.00. Following the transaction, the director now owns 2,638,490 shares in the company, valued at $87,334,019. This trade represents a 7.31% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Robert James Gamgort also recently made the following trade(s):

  • On Thursday, May 1st, Robert James Gamgort sold 208,000 shares of Keurig Dr Pepper stock. The stock was sold at an average price of $34.12, for a total transaction of $7,096,960.00.
  • On Tuesday, April 29th, Robert James Gamgort sold 208,000 shares of Keurig Dr Pepper stock. The shares were sold at an average price of $33.96, for a total transaction of $7,063,680.00.

Keurig Dr Pepper Stock Performance

Shares of NASDAQ:KDP traded up $0.21 on Friday, reaching $32.77. The company's stock had a trading volume of 7,843,069 shares, compared to its average volume of 10,731,085. Keurig Dr Pepper Inc. has a 52-week low of $30.12 and a 52-week high of $38.28. The stock has a market capitalization of $44.51 billion, a P/E ratio of 19.86, a PEG ratio of 2.42 and a beta of 0.48. The stock's 50-day moving average is $34.08 and its two-hundred day moving average is $33.04. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.53 and a quick ratio of 0.36.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.38 by $0.04. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The firm had revenue of $3.64 billion during the quarter, compared to the consensus estimate of $3.57 billion. During the same period in the prior year, the business earned $0.38 EPS. The firm's revenue was up 4.8% compared to the same quarter last year. As a group, sell-side analysts forecast that Keurig Dr Pepper Inc. will post 1.92 EPS for the current year.

Keurig Dr Pepper Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be issued a dividend of $0.23 per share. This represents a $0.92 annualized dividend and a dividend yield of 2.81%. The ex-dividend date of this dividend is Friday, June 27th. Keurig Dr Pepper's dividend payout ratio is presently 83.64%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. Barclays boosted their price objective on Keurig Dr Pepper from $37.00 to $38.00 and gave the stock an "overweight" rating in a research report on Monday, April 28th. JPMorgan Chase & Co. upped their price objective on Keurig Dr Pepper from $37.00 to $40.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. Wells Fargo & Company reiterated an "overweight" rating on shares of Keurig Dr Pepper in a report on Tuesday, February 25th. Royal Bank of Canada restated an "outperform" rating and set a $42.00 target price on shares of Keurig Dr Pepper in a research note on Tuesday, April 22nd. Finally, UBS Group upped their price target on Keurig Dr Pepper from $40.00 to $42.00 and gave the company a "buy" rating in a report on Thursday, April 17th. Four analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $39.33.

View Our Latest Report on KDP

Hedge Funds Weigh In On Keurig Dr Pepper

A number of large investors have recently bought and sold shares of KDP. Vanguard Group Inc. raised its holdings in Keurig Dr Pepper by 21.3% during the first quarter. Vanguard Group Inc. now owns 145,012,806 shares of the company's stock worth $4,962,338,000 after purchasing an additional 25,425,644 shares in the last quarter. Wellington Management Group LLP lifted its holdings in shares of Keurig Dr Pepper by 10.3% in the 4th quarter. Wellington Management Group LLP now owns 60,602,781 shares of the company's stock valued at $1,946,561,000 after buying an additional 5,646,179 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in shares of Keurig Dr Pepper by 36.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 54,656,384 shares of the company's stock valued at $1,755,564,000 after buying an additional 14,473,054 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Keurig Dr Pepper by 108.1% in the first quarter. JPMorgan Chase & Co. now owns 38,882,672 shares of the company's stock valued at $1,330,565,000 after buying an additional 20,196,835 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in Keurig Dr Pepper by 8.7% during the fourth quarter. Geode Capital Management LLC now owns 24,511,039 shares of the company's stock worth $784,974,000 after acquiring an additional 1,962,195 shares during the period. Hedge funds and other institutional investors own 93.99% of the company's stock.

Keurig Dr Pepper Company Profile

(Get Free Report)

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.

See Also

Insider Buying and Selling by Quarter for Keurig Dr Pepper (NASDAQ:KDP)

Should You Invest $1,000 in Keurig Dr Pepper Right Now?

Before you consider Keurig Dr Pepper, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.

While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines